Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Non-Current Deffered Revenue (2022)

Historic Non-Current Deffered Revenue for 60 Degrees Pharmaceuticals (SXTPW) over the last 1 years, with Q4 2022 value amounting to $255000.0.

  • 60 Degrees Pharmaceuticals' Non-Current Deffered Revenue changed N/A to $255000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $255000.0, marking a year-over-year change of. This contributed to the annual value of $255000.0 for FY2022, which is N/A changed from last year.
  • 60 Degrees Pharmaceuticals' Non-Current Deffered Revenue amounted to $255000.0 in Q4 2022.
  • 60 Degrees Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $255000.0 during Q4 2022, with a 5-year trough of $255000.0 in Q4 2022.